Pharmafile Logo
Pharmafocus logo
Advanced Search

Clinical Research

Showing 5 posts of 5 posts found.

Shane Olwill appointed as chief development officer at Asgard Therapeutics

March 28, 2025 Business Services, Clinical Research Asgard Therapeutics, CDO, Oncology, appointment, immunology

Asgard Therapeutics has announced the appointment of Shane Olwill as chief development officer (CDO). The biotech company develops in vivo …
Appointment

PulseSight Therapeutics closes Series A financing for dry AMD phase 1 clinical study

February 14, 2025 Clinical Research Opthalmology, age-related macular degeneration, clinical trials

Ophthalmology biotech PulseSight Therapeutics has confirmed the closure of its Series A funding round, the proceeds of which will be …
News

Results from Novadip phase 1b/2a trial reveal 88% efficacy

January 28, 2025 Clinical Research Congenital Pseudoarthritis of the Tibia, Rare Diseases, clinical trials, efficacy, paediatric, rare diseases

Novadip Biosciences, a clinical stage biotechnology company with a specialty in regenerative medicine, has announced the results of its 12-month …
News

China CDE clears Phase 3 Study of Lisafltoclax in Newlly Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome

August 13, 2024 Clinical Research, Research and Development Ascentage Pharma, Oncology

The China Centre for Drug Evaluation (CDE) has cleared the registrational phase 3 study of lisaftoclax in combination with azacitadine …
News

Drug discovery and development partnership announced between Apollo Therapeutics and Oxford University

July 31, 2024 Clinical Research, Medical Communications, Research and Development Apollo Therapeutics, Internal Medicine, Microbiology, drug development, drug discovery, research

Portfolio therapeutics company Apollo Therapeutics has announced earlier this week that it will provide capital and expertise to Oxford University’s …
News
The Gateway to Local Adoption Series

Latest content

Safeguarding health and well-being for employees – the value of occupational health services

December 1, 2025

Men’s health – a new report from the Department of Health and Social Care

November 28, 2025

Healing the fracture in the system: the case for universal fraction liaison services access

November 28, 2025

Five Facts about antimicrobial resistance

November 28, 2025

Celltrion’s Remsima IV approved by EC in liquid form

November 27, 2025